Difference between revisions of "Kahn M, et al. Nat. Rev. Drug Discov. (2014) cited as Ref 122 in DOI: 10.1038/s41392-020-0110-5 (Q9385)"
Jump to navigation
Jump to search
(Created claim: Volume (P103): 13, #quickstatements; #temporary_batch_1590009084631) |
(Created claim: Page(s) (P105): 513-532, #quickstatements; #temporary_batch_1590074839150) |
||
| (One intermediate revision by the same user not shown) | |||
| Property / title | |||
| + | Can we safely target the WNT pathway? (English) | ||
| Property / title: Can we safely target the WNT pathway? (English) / rank | |||
| + | Normal rank | ||
| Property / Page(s) | |||
| + | 513-532 | ||
| Property / Page(s): 513-532 / rank | |||
| + | Normal rank | ||
Latest revision as of 15:31, 21 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Kahn M, et al. Nat. Rev. Drug Discov. (2014) cited as Ref 122 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Kahn M
0 references
2014
0 references
Nat. Rev. Drug Discov.
0 references
13
0 references
Can we safely target the WNT pathway? (English)
0 references
513-532
0 references
